BPV offers investment in Keratec owner

By staff reporter

- Last updated on GMT

Related tags Venture capital

BioPacificVentures has made an offer to acquire an eight per cent
share in Wool Equities, owner of New Zealand biotech Keratec - and
sources say it may seek a full take-over position.

BioPacificVentures (BPV) is a venture capital fund aimed at investing in Australiasian life sciences companies with the potential to become international leaders in their field.

The news that BPV has sent a letter to Wool Equities' shareholders offering to buy an eight percent stake at NZ$0.90 per share is a major validation for Keratec's business; a major investor in BPV is Swiss food giant Nestle, which is positioning to be a major force in health and wellness.

Keratec unveiled its sheeps-wool derived keratin to the joint health market in early 2005, and earlier this year a version aimed at skin health - both oral and topical.

The ingredient is typical of New Zealand's sustainable approach to innovation, since it developed a method of extracting it from wool in a soluble, digestible form by separating wool fibre into its constituent keratin parts without destroying its natural amino acid structure. This means different parts of the fibre can be used for different kinds of products and applications.

A source close to Wool Equities told NutraIngredients-USA.com that BPV is looking to increase its share to a take over position of 20 per cent.

Neither BioPacificVentures nor Wool Equities has issued a public statement on the matter. According to press reports the offer for the eight per cent acquisition expires on December 5 at 5pm.

Related news

Related products

show more

Collagen Peptides for a Young and Beautiful Look

Collagen Peptides for a Young and Beautiful Look

Content provided by Gelita AG | 16-May-2023 | White Paper

VERISOL® has been the go-to ingredient in the nutricosmetics market since its launch in 2012, with more than 3.5 million consumers now taking it daily...

Perfect Partner for Bone Health

Perfect Partner for Bone Health

Content provided by INNOBIO Corporation Limited | 02-May-2023 | White Paper

People over 50 need to pay attention to calcium supplementation, especially women.

Skin microbiome: a research guide

Skin microbiome: a research guide

Content provided by Atlantia Clinical Trials | 04-Apr-2023 | White Paper

Validating claims is very important and there is an array of options available.

Related suppliers

Follow us


View more